Evidence map›Paper›PMID 19834714›Full record

ArticleWorld journal of urology2010

Arsenic exposure predicts bladder cancer survival in a US population.

Ryan C Kwong, Margaret R Karagas, Karl T Kelsey, Rebecca A Mason, Sam A Tanyos, Alan R Schned, Carmen J Marsit, Angeline S Andrew

Open access · greenAbstract read
In one paragraph

Article in World journal of urology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ryan C KwongSection of Biostatistics and Epidemiology, Department of Community and Family Medicine, Norris Cotton Cancer Center, Dartmouth Medical School, 7927 Rubin 860 One Medical Center Drive, Lebanon, NH 03756, USA.
Margaret R Karagas
Karl T Kelsey
Rebecca A Mason
Sam A Tanyos
Alan R Schned
Carmen J Marsit
Angeline S Andrew
Dartmouth College · USBrown University · USCenter for Environmental Health · US

Funding

VARIATION IN BIOACCUMULATION AND BIOMAGNIFICATION OF METALS IN NORTHERN US LAKESP42ES007373 · NIEHS · DARTMOUTH COLLEGE · PI STANTON, BRUCE A. · 1995 to 2019
$52.0M
THE ROLE OF CAL IN CIF-MEDIATED DEGRADATION OF CFTRP20RR018787 · NCRR · DARTMOUTH COLLEGE · PI GRISWOLD, KARL E · 2003 to 2011
$21.9M
NONMELANOMA SKIN CANCER IN NEW HAMPSHIRER01CA057494 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 1993 to 2015
$10.9M
The Molecular Epidemiology of Bladder CancerR01CA121147 · NCI · BROWN UNIVERSITY · PI KELSEY, KARL TIMOTHY · 2007 to 2010
$2.0M
Bladder Cancer Prognostic IndicatorsK07CA102327 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2005 to 2009
$819k
DNA Repair and Bladder CancerR03CA099500 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2003 to 2004
$158k
Comprehensive Assessment of Bladder Cancer Genetic SusceptibilityR03CA121382 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2006 to 2007
$158k
NCI NIH HHS K07 CA102327NCI NIH HHS R01 CA057494NCI NIH HHS R01 CA121147NCI NIH HHS R01 CA57494NCI NIH HHS R03 CA099500NCI NIH HHS R03 CA121382NCI NIH HHS R03 CA99500NCRR NIH HHS P20 RR018787NIEHS NIH HHS P42 ES007373NIEHS NIH HHS P42 ES07373
6 · The paper itself

Abstract

purposeChronic arsenic exposure at levels found in US drinking water has been associated with bladder cancer. While arsenic is a known carcinogen, recent studies suggest that it is useful as a therapeutic agent for leukemia. This study examined the relationship between arsenic exposure and bladder cancer mortality.

methodsWe studied 832 cases of bladder cancer diagnosed in New Hampshire from a population-based case-control study. Individual exposure to arsenic was determined in home drinking water using ICP-MS and in toenail samples by instrumental neutron activation analysis.

resultsAmong the high arsenic exposure group, found using toenail arsenic level or arsenic consumption, cases experienced a de-escalated survival hazard ratio (HR) [high (> or =75 percent) versus low (<25th percentile) toenail arsenic overall survival HR 0.5 (95% CI 0.4-0.8)], controlled for tumor stage, grade, gender, age and treatment regimen. This association was found largely among invasive tumors, in smokers and was not modified by TP53 status. Bladder cancer cause-specific survival showed a similar trend, but did not reach statistical significance [HR 0.5 (95% CI 0.3-1.1)].

conclusionsArsenic exposure may be related to the survival of patients with bladder cancer.

Indexed as

AdultAgedArsenicCase-Control StudiesEnvironmental ExposureFemaleHumansMaleMiddle AgedNailsNew HampshirePredictive Value of TestsRisk FactorsRisk Reduction BehaviorSmokingSurvival AnalysisArsenic

Identifiers

PMID19834714
PMCPMC3296964
OpenAlexW2035310883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.